Rhone-Poulenc Rorer
Executive Summary
Management of newly acquired Rorer will include: Chairman, CEO and President Robert Cawthorn; Randy Thurman, exec VP and group president of the businesses in the U.S., Canada, Japan, Korea, Australia, New Zealand, Mexico, Puerto Rico, Central America, Armour Pharmaceuticals, worldwide manufacturing and materials management; Jean-Jacques Bertrand, exec VP and group president of operations in Europe, Africa, South America, Near and Middle East and the Far East outside Japan and Korea; James Tretter, PhD, senior VP and president, Rhone-Poulenc Rorer Central Research; Patrick Langlois, senior VP and chief financial officer; John Bartlett, senior VP, general counsel and secretary; Gilles Brisson, senior VP-corporate development; Steven Baumgartner, senior VP-human resources and public affairs; and James Yahres, director of investor relations.
You may also be interested in...
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.
Xaira Launches With $1bn-Plus And End-To-End AI Strategy
ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.